Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery

Clinical trial NCT00846807 · COMPLETED

Trial details

NCT number: NCT00846807
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Arthroplasty, Replacement Thromboembolism

Start date: 2009-02-01
Primary completion: 2011-07-01
Enrollment: 5476

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.